awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39097668-667E6245-8654-4238-9508-0A579E61EFD4
Q39097668-667E6245-8654-4238-9508-0A579E61EFD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39097668-667E6245-8654-4238-9508-0A579E61EFD4
Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.
P2860
Q39097668-667E6245-8654-4238-9508-0A579E61EFD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39097668-667E6245-8654-4238-9508-0A579E61EFD4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d74ba48647a4820f516af84e510b3b83cc70329
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res